Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2–Altered ...
In a recent study published in Science Immunology, researchers explore gene expression profiles of distinct populations of intraepithelial lymphocytes (IELs), particularly T-cell IELs (T-IELs), within ...
Afamitresgene-autoleucel is an autologous T-cell immunotherapy designed to target cancer cells in solid tumors expressing melanoma-associated antigen A4. The Food and Drug Administration (FDA) has ...
Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying a specific gene improves the ability of immune cells to combat cancer for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results